Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01021683
What this trial is testing

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Who this might be right for
Hematologic NeoplasmsNeutropeniaFever
Janssen Korea, Ltd., Korea 203
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06547866
What this trial is testing

Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
French Innovative Leukemia Organisation 102
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT01233895
What this trial is testing

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sanofi 26
Early research (Phase 1)Study completedNCT00272857
What this trial is testing

Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia

Who this might be right for
Fanconi Anemia
Boston Children's Hospital 3
Not applicableStudy completedNCT01446783
What this trial is testing

IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients

Who this might be right for
Ehlers-Danlos Syndrome, Classic
Bispebjerg Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817241
What this trial is testing

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 5
Not applicableStudy completedNCT07069153
What this trial is testing

Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients

Who this might be right for
Oral MucositisHead and Neck NeoplasmsHematologic Neoplasms
University of Pavia 40
Not applicableUnknownNCT05403970
What this trial is testing

Correlation of Various Laboratory Parameters With Outcome in Patients Suffering From Acute Non-traumatic Subarachnoid Hemorrhage - Prospective Case Series

Who this might be right for
Subarachnoid Hemorrhage
University of Debrecen 300
Not applicableUnknownNCT03419494
What this trial is testing

Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients

Who this might be right for
Adult Acute Lymphoblastic Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796256
What this trial is testing

Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
PNH - Paroxysmal Nocturnal Hemoglobinuria
Suzhou Sanegene Bio Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192237
What this trial is testing

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 40
Not applicableUnknownNCT03915873
What this trial is testing

Evaluation of Bleeding Score in Egyptian Patients With vWD Type I and Correlate it With Laboratory Parameters

Who this might be right for
Von Willebrand Disease, Type 1
Assiut University 20
Testing effectiveness (Phase 2)Study completedNCT00241241
What this trial is testing

Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

Who this might be right for
Polycythemia Vera
PV-Nord 40
Not applicableStudy completedNCT04144205
What this trial is testing

Effect of Arterial Oxygen Partial Pressure on Mixed Venous Oxygen Saturation

Who this might be right for
Anemia
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01615029
What this trial is testing

Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 45
Large-scale testing (Phase 3)UnknownNCT05467319
What this trial is testing

Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS

Who this might be right for
Gynecologic CancerAnemia, Iron DeficiencySurgery
Alberta Health Services, Calgary 82
Testing effectiveness (Phase 2)Study completedNCT00089167
What this trial is testing

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05535244
What this trial is testing

A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 90
Next Page